Macquarie Group’s Usana Health Sciences USNA Stock Holding History

Macquarie Group’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-78	Closed	-$2.1K	–	1776
2025 Q1	$2.1K	Buy	+78	New	+$2.47K	﹤0.01%	1703
2022 Q3	–	Sell	-252	Closed	-$16.7K	–	2302
2022 Q2	$18K	Hold	252	–	–	﹤0.01%	2342
2022 Q1	$20	Hold	252	–	–	﹤0.01%	2394
2021 Q4	$26K	Hold	252	–	–	﹤0.01%	2344
2021 Q3	$23K	Hold	252	–	–	﹤0.01%	2430
2021 Q2	$26K	Hold	252	–	–	﹤0.01%	2311
2021 Q1	$25K	Sell	252 -119	-32%	-$10.8K	﹤0.01%	2233
2020 Q4	$29K	Hold	371	–	–	﹤0.01%	2153
2020 Q3	$27K	Buy	371 +103	+38%	+$8.26K	﹤0.01%	2097
2020 Q2	$20K	Buy	+268	New	+$21K	﹤0.01%	2168
2019 Q1	–	Sell	-700	Closed	-$82K	–	2045
2018 Q4	$82K	Buy	700 +78	+13%	+$9.02K	﹤0.01%	1529
2018 Q3	$75K	Sell	622 -100	-14%	-$12.4K	﹤0.01%	1650
2018 Q2	$83K	Sell	722 -800	-53%	-$87.5K	﹤0.01%	1879
2018 Q1	$131K	Sell	1,522 -2,500	-62%	-$194K	﹤0.01%	1816
2017 Q4	$298K	Buy	+4,022	New	+$269K	﹤0.01%	1612

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Macquarie Group's USNA Position: Q2 2025 in Review

Macquarie Group sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 78 shares — an estimated $2.1K sold.

Macquarie Group first reported a position in USNA in Q4 2017 and held it in 15 quarters. The position peaked at $298K in Q4 2017. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.

Macquarie Group reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
Macquarie Group sold 78 Usana Health Sciences shares in Q2 2025, an estimated $2.1K.
Macquarie Group first reported a position in Usana Health Sciences in Q4 2017 and held it in 15 quarters.
Macquarie Group's Usana Health Sciences position peaked at $298K in Q4 2017.
164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.

Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.